Treatment of Meibomian Gland Dysfunction Prior to Cataract Surgery
Pilot Study for Treatment of Meibomian Gland Dysfunction (MGD) Prior to Cataract Surgery
Sponsor: TearScience, Inc.
A NA clinical study on Blepharitis and Dry Eye Syndrome, this trial is completed. The trial is conducted by TearScience, Inc. and has accumulated 11 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
▶ Show 6 earlier versions
-
Jan 2021 — Dec 2022 [monthly]
Completed NA
-
Oct 2018 — Jan 2021 [monthly]
Completed NA
-
Jul 2018 — Oct 2018 [monthly]
Completed NA
-
Jun 2018 — Jul 2018 [monthly]
Completed NA
-
Feb 2017 — Jun 2018 [monthly]
Completed NA
-
Jan 2017 — Feb 2017 [monthly]
Completed NA
First recorded
Mar 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- TearScience, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .